Journal article 910 views
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
Ceri Phillips
CNS Drugs, Volume: 18, Issue: 9, Pages: 561 - 574
Swansea University Author: Ceri Phillips
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.2165/00023210-200418090-00002
Abstract
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
| Published in: | CNS Drugs |
|---|---|
| ISSN: | 1172-7047 |
| Published: |
2004
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa1249 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Item Description: |
The journal commissioned this research which sought to draw the issues relating to cost-effectiveness of therapies in multiple sclerosis together following considerable discussion and debate in academic/policy arenas. Comprised of a systematic review of the worlds' literature and an assessment of published economic models from across the world. |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
9 |
| Start Page: |
561 |
| End Page: |
574 |